teysuno
nordic group b.v. - тегафур, gimeracil, oteracil - nowotwory żołądka - Środki przeciwnowotworowe - teysuno is indicated in adults:- for the treatment of advanced gastric cancer when given in combination with cisplatin (see section 5. - as monotherapy or in combination with oxaliplatin or irinotecan, with or without bevacizumab, for the treatment of patients with metastatic colorectal cancer for whom it is not possible to continue treatment with another fluoropyrimidine due to hand-foot syndrome or cardiovascular toxicity that developed in the adjuvant or metastatic setting.
rosuvastatin medical valley 5 mg tabletki powlekane
medical valley invest ab - rosuvastatin calcium - tabletki powlekane - 5 mg
zydelig
gilead sciences ireland uc - idelalisib - lymphoma, non-hodgkin; leukemia, lymphocytic, chronic, b-cell - antineoplastic agents, other antineoplastic agents - zydelig is indicated in combination with an anti‑cd20 monoclonal antibody (rituximab or ofatumumab) for the treatment of adult patients with chronic lymphocytic leukaemia (cll):who have received at least one prior therapy, oras first line treatment in the presence of 17p deletion or tp53 mutation in patients who are not eligible for any other therapies. zydelig is indicated as monotherapy for the treatment of adult patients with follicular lymphoma (fl) that is refractory to two prior lines of treatment.
desmoxan 1,5 mg tabletki
aflofarm farmacja polska sp. z o.o. - cytisinum - tabletki - 1,5 mg
depepsit met 100 mg + 1000 mg tabletki o zmodyfikowanym uwalnianiu
adamed pharma s.a. - sitagliptin hydrochloride monohydrate + metformini hydrochloridum - tabletki o zmodyfikowanym uwalnianiu - 100 mg + 1000 mg
depepsit met 50 mg + 1000 mg tabletki o zmodyfikowanym uwalnianiu
adamed pharma s.a. - sitagliptin hydrochloride monohydrate + metformini hydrochloridum - tabletki o zmodyfikowanym uwalnianiu - 50 mg + 1000 mg
depepsit met 50 mg + 500 mg tabletki o zmodyfikowanym uwalnianiu
adamed pharma s.a. - sitagliptin hydrochloride monohydrate + metformini hydrochloridum - tabletki o zmodyfikowanym uwalnianiu - 50 mg + 500 mg
sitagliptin + metformin hydrochloride apc 100 mg + 1000 mg tabletki o zmodyfikowanym uwalnianiu
apc instytut sp. z o.o. - sitagliptin hydrochloride monohydrate + metformini hydrochloridum - tabletki o zmodyfikowanym uwalnianiu - 100 mg + 1000 mg
sitagliptin + metformin hydrochloride apc 50 mg + 500 mg tabletki o zmodyfikowanym uwalnianiu
apc instytut sp. z o.o. - sitagliptin hydrochloride monohydrate + metformini hydrochloridum - tabletki o zmodyfikowanym uwalnianiu - 50 mg + 500 mg
sitagliptin + metformin hydrochloride apc 50 mg + 1000 mg tabletki o zmodyfikowanym uwalnianiu
apc instytut sp. z o.o. - sitagliptin hydrochloride monohydrate + metformini hydrochloridum - tabletki o zmodyfikowanym uwalnianiu - 50 mg + 1000 mg